Drugs that contain Bupropion Hydrobromide
1. Drug name - APLENZIN
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7569610 | BAUSCH | Modified release formulations of a bupropion salt |
Jun, 2026
(3 years from now) | |
| US7585897 | BAUSCH | Modified release formulations of a bupropion salt |
Jun, 2026
(3 years from now) | |
| US7572935 | BAUSCH | Modified release formulations of a bupropion salt |
Jun, 2026
(3 years from now) | |
| US7662407 | BAUSCH | Modified release formulations of a bupropion salt |
Jun, 2026
(3 years from now) | |
| US7645802 | BAUSCH | Bupropion hydrobromide and therapeutic applications |
Jun, 2026
(3 years from now) | |
| US7671094 | BAUSCH | Bupropion hydrobromide and therapeutic applications |
Jun, 2026
(3 years from now) | |
| US7649019 | BAUSCH | Modified release formulations of a bupropion salt |
Jun, 2026
(3 years from now) | |
| US7241805 | BAUSCH | Modified release formulations of a bupropion salt |
Jun, 2026
(3 years from now) | |
Treatment: Treatment of major depressive disorder by dosing at intervals of 24 hours
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 174MG | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| 348MG | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| 522MG | TABLET, EXTENDED RELEASE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.